Recital 12, Regulation (EU) 2024/2699

In forcesince 18 Oct 2024

Under Article 30(1) of Regulation (EU) 2021/2282, the Commission is to set up and maintain an IT platform consisting of a secure system for the exchange of information on the joint work, including the exchange of information with the European Medicines Agency (‘the HTA IT platform’). The Commission and the European Medicines Agency will be working towards the interoperability of the HTA IT platform and the IT systems of the European Medicines Agency, which will however not be in place by the date of application of Regulation (EU) 2021/2282, that is 12 January 2025. It is therefore necessary to specify that the HTA secretariat and the European Medicines Agency should exchange the information within the context of joint clinical assessment and joint scientific consultation as appropriate through the HTA IT platform.